The Effect of Probiotics (MCP<sup>®</sup> BCMC<sup>®</sup> Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease

The Effect of Probiotics (MCP<sup>®</sup> BCMC<sup>®</sup> Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease

Treatment for non-alcoholic fatty liver disease (NAFLD) currently consists of lifestyle modifications such as a low-fat diet, weight loss, and exercise. The gut microbiota forms part of the gut–liver axis and serves as a potential target for NAFLD treatment. We investigated the effect of probiotics...

Full description

Bibliographic Details
Main Authors: Mohamad Hizami Mohamad Nor, Nurainina Ayob, Norfilza M. Mokhtar, Raja Affendi Raja Ali, Geok Chin Tan, Zhiqin Wong, Nor Hamizah Shafiee, Yin Ping Wong, Muaatamarulain Mustangin, Khairul Najmi Muhammad Nawawi
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Nutrients
Subjects:
NAFLD
probiotics
gut microbiota
mucosal immune function
intestinal permeability
Online Access:https://www.mdpi.com/2072-6643/13/9/3192

Internet

https://www.mdpi.com/2072-6643/13/9/3192

Similar Items